Fidelity Investments’s HUMANIGEN, INC. HGEN Stock Holding History

Fidelity Investments’s Portfolio HGEN Stock Details HGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1	Closed	–	–	5607
2022 Q4	$0	Buy	+1	New	–	﹤0.01%	5646
2022 Q3	–	Sell	-121,730	Closed	-$215K	–	5553
2022 Q2	$215K	Sell	121,730 -8,772	-7%	-$19.7K	﹤0.01%	3107
2022 Q1	$393K	Buy	+130,502	New	+$349K	﹤0.01%	3060
2021 Q3	–	Sell	-1	Closed	–	–	5245
2021 Q2	$0	Buy	+1	New	+$18	﹤0.01%	5088

Other funds holding HGEN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

LSA

Leonteq Securities AG Zurich, Switzerland $2.91B AUM 56.5% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments's HGEN Position: Q1 2023 in Review

Fidelity Investments sold out of HUMANIGEN, INC. (HGEN) in Q1 2023, closing a stake of 1 share.

Fidelity Investments first reported a position in HGEN in Q2 2021 and held it in 4 quarters. The position peaked at $393K in Q1 2022. 42 funds tracked by Wall St. Rank hold HGEN as of Q1 2023.

Fidelity Investments reported no remaining HUMANIGEN, INC. position as of Q1 2023 after selling out during the quarter.
Fidelity Investments sold 1 HUMANIGEN, INC. share in Q1 2023.
Fidelity Investments first reported a position in HUMANIGEN, INC. in Q2 2021 and held it in 4 quarters.
Fidelity Investments's HUMANIGEN, INC. position peaked at $393K in Q1 2022.
42 funds tracked by Wall St. Rank held HUMANIGEN, INC. as of Q1 2023.

Based on Fidelity Investments's 13F filing for Q1 2023, filed 11 May 2023.